New advances in multiple sclerosis therapy
Pharmacists in community-based practice.
Universal program number: 0401-0000-13-001-H01-P
Activity type: Knowledge-based
To improve the pharmacist’s ability to provide consultation on current pharmacological options and treatment strategies for multiple sclerosis.
Multiple sclerosis is an inflammatory, autoimmune disease of the central nervous system that often presents in individuals between their second and fourth decade of life. The primary sequelae of MS is demyelination, or recurrent inflammatory destruction of the myelin sheath, which serves as a protective insulation of white matter in the brain and spinal cord to improve nerve-signaling conduction. When the myelin is destroyed, this results in incomplete and poor nerve conduction and transmission. This destruction can potentially lead to many adverse consequences and significantly affect patients during their life’s peak productive years. MS symptoms are often dependent on the severity, extension and location of areas of inflammation, as well as the course of the disease.1
Upon completion of this program, the pharmacist should be able to:
- Identify primary signs and symptoms of multiple sclerosis.
- Select pharmacotherapy for treating acute exacerbations of multiple sclerosis and spasticity associated with MS.
- Compare disease-modifying therapies utilized in the chronic treatment of multiple sclerosis.
- Evaluate the appropriateness of pharmacological therapy for a patient with multiple sclerosis.
- Provide information and counseling to patients with MS on their drug therapy to help with medication adherence and appropriate medication use.
To obtain credit:
A minimum test score of 70% is needed to obtain credit. Submit your answers to the learning assessment questions online at DrugStoreNewsCE.com. Your statement of credit will be available through CPE Monitor located at NABP.net. To ensure transmission of credit hours to CPE Monitor, you must enter your correct e-PID number in your CE profile.
All customer service questions should be directed to (800) 933-9666.
If you are a paid enrollee, there is no cost to participate in this lesson. The fee for participants who are not enrolled is $13.95.
Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE Activity is approved for pharmacists and is worth 2.0 contact hours (0.2 CEUs). The activity is available for CE credit through Feb. 1, 2016.
By Clayton D. English, PharmD, assistant professor, Department of Pharmacy Practice at Albany College of Pharmacy and Health Sciences — Vermont Campus
Clayton D. English and the DSN editorial and continuing education staff do not have any actual or potential conflicts of interest in relation to this lesson.
- 2.00 Pharmacist